Trial Profile
Nabpaclitaxel plus gemcitabine as induction chemotherapy (CT) followed by chemoradiation (CRT) in locally advanced pancreatic cancer (LAPC).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 02 Oct 2015 New trial record